Jim Cramer made the following calls on October 2nd, 2013. What do you think about his picks?
Yahoo! Inc. (NASDAQ:YHOO): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on July 17, 2013. The stock’s 52-week high is $34.70, and its 52-week low is $15.65. Cramer was optimistic about Yahoo, claiming that the stock still had room to grow. Yahoo has recently been in the news when outrage erupted over its policy of sending a coupon for a free t-shirt to people who independently report bugs to the company. The $12.50 equity of the t-shirt is far less than the several thousand dollar standard in the industry, and Yahoo has already announced a revamped program to be instituted by the end of this month.
Remax (NYSE:RMAX): Jim Cramer ranked this stock a Sell. The stock’s 52-week high is $0.00, and its 52-week low is $0.00. Cramer wondered how the IPO of Remax could have gone so well considering the state of the economy; a potential debt default would have disastrous consequences for the real estate market. Cramer took a cautious attitude toward the company, preferring not to invest in a new company or in the sector at this point in time because he felt as if he is one of few who is properly factoring in the potential downside of the shares.
The Travelers Companies, Inc. (NYSE:TRV): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on May 2, 2013. The stock’s 52-week high is $89.00, and its 52-week low is $67.77. Cramer was favorable toward Travelers, citing them as one of the better picks in the sector. The company has recently been upgraded by several firms, and it is one of the few insurance companies found on the Dow Jones Sustainability Index.
United Therapeutics Corp. (NASDAQ:UTHR): Jim Cramer ranked this stock a Buy. The stock’s 52-week high is $83.74, and its 52-week low is $44.51. Cramer claimed that United Therapeutics is “so good,” and that the stock is a true winner. When examining user-submitted portfolios, Cramer pointed to the lack of pharmaceutical stocks as a perennial weakness, making United Therapeutics all the more attractive to an investor looking to diversify into the area.
Polaris Industries, Inc. (NYSE:PII): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on October 22, 2012. The stock’s 52-week high is $131.21, and its 52-week low is $78.83. Cramer was a fan of Polaris Industries, a company that has been on the upswing since May of this year and is currently trading very near to its 52-week high.